Nyström M - Search Results

1

Conditional nuclear localization of hMLH3 suggests a minor activity in mismatch repair and supports its role as a low-risk gene in HNPCC.

Korhonen MK, Raevaara TE, Lohi H, Nyström M. Korhonen MK, et al. Among authors: nystrom m. Oncol Rep. 2007 Feb;17(2):351-4. Oncol Rep. 2007. PMID: 17203173

2

APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers.

Kariola R, Abdel-Rahman WM, Ollikainen M, Butzow R, Peltomäki P, Nyström M. Kariola R, et al. Among authors: nystrom m. Fam Cancer. 2005;4(2):187-90. doi: 10.1007/s10689-004-6130-4. Fam Cancer. 2005. PMID: 15951972

3

Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1.

Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lönnqvist KE, Holinski-Feder E, Sutter C, McKinnon W, Duraisamy S, Gerdes AM, Peltomäki P, Kohonen-Ccorish M, Mangold E, Macrae F, Greenblatt M, de la Chapelle A, Nyström M. Raevaara TE, et al. Among authors: nystrom m. Gastroenterology. 2005 Aug;129(2):537-49. doi: 10.1016/j.gastro.2005.06.005. Gastroenterology. 2005. PMID: 16083711

4

The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.

Ollila S, Fitzpatrick R, Sarantaus L, Kariola R, Ambus I, Velsher L, Hsieh E, Andersen MK, Raevaara TE, Gerdes AM, Mangold E, Peltomäki P, Lynch HT, Nyström M. Ollila S, et al. Among authors: nystrom m. Int J Oncol. 2006 Jan;28(1):149-53. Int J Oncol. 2006. PMID: 16327991

5

Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.

Ollila S, Sarantaus L, Kariola R, Chan P, Hampel H, Holinski-Feder E, Macrae F, Kohonen-Corish M, Gerdes AM, Peltomäki P, Mangold E, de la Chapelle A, Greenblatt M, Nyström M. Ollila S, et al. Among authors: nystrom m. Gastroenterology. 2006 Nov;131(5):1408-17. doi: 10.1053/j.gastro.2006.08.044. Epub 2006 Aug 22. Gastroenterology. 2006. PMID: 17101317

6

Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR).

Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, Raevaara T, Ollila S, Nyström M, Grimm AJ, Christodoulou J, Oetting WS, Greenblatt MS. Chan PA, et al. Among authors: nystrom m. Hum Mutat. 2007 Jul;28(7):683-93. doi: 10.1002/humu.20492. Hum Mutat. 2007. PMID: 17370310

7

Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification.

Ollila S, Dermadi Bebek D, Greenblatt M, Nyström M. Ollila S, et al. Among authors: nystrom m. Int J Cancer. 2008 Aug 1;123(3):720-4. doi: 10.1002/ijc.23573. Int J Cancer. 2008. PMID: 18470917

8

The first functional study of MLH3 mutations found in cancer patients.

Korhonen MK, Vuorenmaa E, Nyström M. Korhonen MK, et al. Among authors: nystrom m. Genes Chromosomes Cancer. 2008 Sep;47(9):803-9. doi: 10.1002/gcc.20581. Genes Chromosomes Cancer. 2008. PMID: 18521850

9

Mechanisms of pathogenicity in human MSH2 missense mutants.

Ollila S, Dermadi Bebek D, Jiricny J, Nyström M. Ollila S, et al. Among authors: nystrom m. Hum Mutat. 2008 Nov;29(11):1355-63. doi: 10.1002/humu.20893. Hum Mutat. 2008. PMID: 18951462

10

Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients.

Christensen LL, Kariola R, Korhonen MK, Wikman FP, Sunde L, Gerdes AM, Okkels H, Brandt CA, Bernstein I, Hansen TV, Hagemann-Madsen R, Andersen CL, Nyström M, Ørntoft TF. Christensen LL, et al. Among authors: nystrom m. Fam Cancer. 2009;8(4):489-500. doi: 10.1007/s10689-009-9274-4. Epub 2009 Aug 21. Fam Cancer. 2009. PMID: 19697156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters